Tweet
Results from my 3 year Anniversary psa was 0.03 which is still considered undetectable by Mayo Clinic. Maybe have beat this or at least will stay undetectable for a loooong time.
-
DOB 1955 63 at Dx
3/2018 PSA 4.05 DRE Normal Refered to Uro PSA 10/2018 6.28
Bx 11/2018 12 Cores 3 Pos 1-5% LM 2-50% LLB 3-50% LB
GS 3+4=7 T1c Consult Mayo Clinic Phoenix Az 1/4/2019
MRI w/Coil 2/27/2019 for surgery planning Mayo Az
RALP 2/28/2019 Mayo Clinic Az Dr. Paul Andrews Recommend
Path: GS 3+4=7 Tertiary Gleason Pattern none, Grade Group 2
Tumor moderate to extensive volume mainly posterior portion of prostate
Largest nodule measures 8mm
Prostate: 21g 3.5x3x3 cm
EPE: Neg - BNI: Neg - SVI: Pos Left SV - Margins: Pos LLB & CB 2mm focus each - LN Ex: 16 LN Involved 0 - Nerves Spared Right Side
Path Staging pT3b pNO MX
Continence: 99% at 9 wks - ED: Present
PSA 4/17/19 < 0.10
PSA 5/2/2019 < 0.007
PSA 6/10/2019 < 0.10
PSA 8/1/2019 < 0.007
PSA 9/16/2019 < 0.10
PSA 12/16/2019 < 0.10
PSA 3/23/2020 < 0.007
PSA 7/2/2020 < 0.007
PSA 11/9/2020 0.064 uh-oh
PSA 5/3/2021 < 0.10
PSA 11/3/2021 <0.10
PSA 4/29/2022 0.03 -
Congrats and hope you get that loooong time.YOB 1957
DX 12/18, GS 8, 4+4 6/12 cores, LL Apex 100%, LM Apex 60%, LL Mid 50%, LMM 40%, LL Base 5%, LM <5%, Right side negative.
3/6/19. Post surgery Pathology Report - Grade Group 4 Intraductal Carcinoma
T3aNO, <1 mm non focal EPE, GS8, 21 mm uni-focal tumor involved 10% of prostate.
7 Nodes, SV, SM, PNI, and BNI were negative.
LVI and Cribriform pattern present.
Decipher .86 High Risk.
Post Surgery PSA
3/25/19 .03. (25 days)
4/25/19 <.03. (2 months)
5/25/19 <.02 (3 months)
9/10/2019. <.02 (7 months)
11/27/2019. <.02. T < 3 (9 months)
5/19/2020. <.02 (15 months)
11/2/2020. <.02 (21 months)
5/11/2021. <.02 T <3 (27 months)
8/25/2021. <.02 T <3 (30 months)
12/6/2021. <.02 T <3 (33 months)
3 Part Modality Treatment Completed
2/25/19 Robotic Laparoendoscopic Single Site Surgery outpatient Cleveland Clinic, Dr. Kaouk, surgery #41 in US.
ART - 7/25/-9/25 2019 (78 Gy, yes, I glow in the dark).
ADT - 5/19- 5/21 Eligard and Casodex.
-
Congrats!
EVen though I "graduated" to annual testing, I decided to have my annual physical and visit from surgeon 6 months apart, with each drawing PSA. That reduced my PSA anxiety a bit, and helped serve for a better baseline and earlier detection if my PSA did rise...BD: 1959 PSA 4.9 11/2012 (no symptoms)
Biopsy 12/2012 Negative
PSA 5.9 05/2013 (still no symptoms)
Biopsy 6/2013 3+4 (thank goodness for PSA tests)
1 core positive (upper left), 1 suspicious (lower left) out of 12
DRE: bump right side T1c; PCA-III = 20 (normala)
Da Vinci 7/18/2013:
Total prostatectomy with seminal vesicles (S13-6085, 1-29, 7/18/13, 29 H&E and 1 paraffin block)
Invasive carcinoma involves left lobe of prostate only, extends from left apex to posterior mid region of left lobe Gleason 7/10 (4+3); G4 tumor comprises 75% of invasive carcinoma present
Estimated total volume of carcinoma in entire prostate gland: 10%
TNM: T2b NX MX (Stage IIA)
PSA History:
8/13 11/13 2/14 8/14 2/15 8/15 3/16, 8/16, 3/17,9/17,4/18, 9/18 PSA "undetectable" (PSA <.1)
March '19 = 0.1
April '19 = 0.10 <-- switched to uPSA tests
June '19 = 0.10
Sept '19 = 0.10
Dec '19 = 0.09
Jan '20 = 0.13
May '20 = 0.2 <- standard test by mistake
Jun '20 = 0.11 <- back to uPSA test
Aug '20 = 0.16
Jan '21 = 0.23
Feb '21 =0.20
Mar '21 - started ADT/HT, radiation scheduled
Jun '21 Eight Weeks Radiation @MSKCC
Jul '21 <.05 (T-Level 0)
Feb '22 <.05 (T-Level back to normal)Comment
-
I would choose 6-month testing, given that you are pT3b and that your last PSA did go up.
Djin69 yr at diagnosis, BPH x 20 yr, 9 (!) negative biopsies, PCA3-
7-05-13 TURP for BPH (90→30 g) path negative for PCa, then 6-mo. checks
6-06-17 Nodule on right + PSA rise on finasteride: 3.6→4.3
6-28-17 Bx #10: 2/14 cores: G10 (5+5) 50% RB, G9 (4+5) 3% RLM
Nodule was negative for PCa
Bone scan, CTs, X-rays: neg.
8-7-17 Open RP, negative frozen sections, Duke Regional Hosp.
SM EPE BNI LVI SVI LNI(5L, 11R): negative, PNI+, nerves spared
pT2c pN0 pMX, G9 (4+5) acinar adenocarcinoma
5% of prostate (4.5 x 5 x 4 cm, 64 g) involved
Dry; ED OK with sildenafil
11-10-17 Decipher score: 0.37, Low Risk:
5-yr met risk: 2.4%, 10-yr PCa-specific mortality: 3.3%9-16-17 (5 wk) PSA <0.1
LabCorp uPSA:
11-28-17 (3 m ) 0.010
02-26-18 (6 m ) 0.009
05-30-18 (9 m ) 0.007 (nadir)
08-27-18 (1 yr.) 0.018 (huh?)
09-26-18 (13 m) 0.013 (retest)
11-26-18 (15 m) 0.012
02-25-19 (18 m) 0.015
05-22-19 (21 m) 0.015
08-28-19 (2 yr. ) 0.016
12-18-19 (28 m) 0.015
06-30-20 (34 m) <0.014
12-30-20 (40 m) 0.037 (?)
03-31-21 (43 m) 0.020
07-13-21(46 m) 0.018
01-25-22(52 m) 0.023Comment
-
Annual testing with SRT less than 24 months ago? 👎YOB 1957
DX 12/18, GS 8, 4+4 6/12 cores, LL Apex 100%, LM Apex 60%, LL Mid 50%, LMM 40%, LL Base 5%, LM <5%, Right side negative.
3/6/19. Post surgery Pathology Report - Grade Group 4 Intraductal Carcinoma
T3aNO, <1 mm non focal EPE, GS8, 21 mm uni-focal tumor involved 10% of prostate.
7 Nodes, SV, SM, PNI, and BNI were negative.
LVI and Cribriform pattern present.
Decipher .86 High Risk.
Post Surgery PSA
3/25/19 .03. (25 days)
4/25/19 <.03. (2 months)
5/25/19 <.02 (3 months)
9/10/2019. <.02 (7 months)
11/27/2019. <.02. T < 3 (9 months)
5/19/2020. <.02 (15 months)
11/2/2020. <.02 (21 months)
5/11/2021. <.02 T <3 (27 months)
8/25/2021. <.02 T <3 (30 months)
12/6/2021. <.02 T <3 (33 months)
3 Part Modality Treatment Completed
2/25/19 Robotic Laparoendoscopic Single Site Surgery outpatient Cleveland Clinic, Dr. Kaouk, surgery #41 in US.
ART - 7/25/-9/25 2019 (78 Gy, yes, I glow in the dark).
ADT - 5/19- 5/21 Eligard and Casodex.
Comment
-
Djin my last one didn't go up.DOB 1955 63 at Dx
3/2018 PSA 4.05 DRE Normal Refered to Uro PSA 10/2018 6.28
Bx 11/2018 12 Cores 3 Pos 1-5% LM 2-50% LLB 3-50% LB
GS 3+4=7 T1c Consult Mayo Clinic Phoenix Az 1/4/2019
MRI w/Coil 2/27/2019 for surgery planning Mayo Az
RALP 2/28/2019 Mayo Clinic Az Dr. Paul Andrews Recommend
Path: GS 3+4=7 Tertiary Gleason Pattern none, Grade Group 2
Tumor moderate to extensive volume mainly posterior portion of prostate
Largest nodule measures 8mm
Prostate: 21g 3.5x3x3 cm
EPE: Neg - BNI: Neg - SVI: Pos Left SV - Margins: Pos LLB & CB 2mm focus each - LN Ex: 16 LN Involved 0 - Nerves Spared Right Side
Path Staging pT3b pNO MX
Continence: 99% at 9 wks - ED: Present
PSA 4/17/19 < 0.10
PSA 5/2/2019 < 0.007
PSA 6/10/2019 < 0.10
PSA 8/1/2019 < 0.007
PSA 9/16/2019 < 0.10
PSA 12/16/2019 < 0.10
PSA 3/23/2020 < 0.007
PSA 7/2/2020 < 0.007
PSA 11/9/2020 0.064 uh-oh
PSA 5/3/2021 < 0.10
PSA 11/3/2021 <0.10
PSA 4/29/2022 0.03Comment
Comment